Anavex Life Sciences Corp (AVXL)

[Doc328]

I noticed at least 4 Law firms are investigating for just Rett issues and 2 initially present the AD issues but a paragraph down also include Rett. If this proceeds, do they end up all combining to do one comprehensive case or would there be two cases (one Rett and one AD)

Law firm PRs just discussing Rett:
Pomerantz
Robbins Geller
Schall
Block and Leviton


Law firm PRs mostly AD with additional mention of Rett:
Levi Korsinsky
Gross


As I stated in a prior post, I saw nothing 'wrong' about the Excellence PRs and data release and feel the Avatar issues could be resolved with a proven timeline of SAP edits (per ICH, these count as protocol amendments and must be reported to the IRB/IEC and FDA or other regulatory agency). I have more concern about AD as multiple Dec 2022 - Jan 2023 PRs/presentations and the Sept 2023 MMRM/LSM PR are mutually exclusive and not just a result of sloppiness.